Background: Hypertension and cancer are both increasing with age. Recently, the new concept of "Onco-Hypertension" has been proposed to address the mutual risks posed by hypertension and cancer and to provide comprehensive care for patients with these two conditions in an aging society.
Methods: In this review, we provide an overview of the current status and future perspective of the "Onco-Hypertension," including our research findings.
Results: Hypertension and cancer share common risk factors and may be interrelated in pathogenesis: Hypertension is involved in the development of certain cancers, and cancer survivors have a higher incidence of hypertension. With recent advances in cancer therapy, the number of cancer survivors has increased. Cancer survivors not only have a higher risk of incident hypertension but also an increased risk of future cardiovascular events, highlighting the growing importance of comprehensive care.
Conclusions: There exists a diverse array of epidemiological and pathophysiological relationships between hypertension and cancer. It is imperative to move the emerging scientific field of "Onco-Hypertension" forward through relentless research efforts.
Keywords: blood pressure; cancer; cardiovascular disease; hypertension; onco-hypertension; oncology.
© The Author(s) 2024. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.